LEVOTEN

This brand name is authorized in Nigeria.

Active ingredients

The drug LEVOTEN contains one active pharmaceutical ingredient (API):

1	Levofloxacin UNII 6GNT3Y5LMF - LEVOFLOXACIN
	Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV.
	Read more about Levofloxacin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
C4-0471	Tablet	LEVOTEN TABLETS 500MG TAB 500 mg 1 X 10	LEVOTEN TABLETS 500MG LEVOTEN LEVOFLOXACIN HEMIHYDRATE USP EQ. TO LEVOFLOXACIN 500MG POM TABLETS 1 X 10 ANTIBIOTIC LIKTENIS REMEDICS LTD 50, UNITY ROAD, OFF IBRAHIM TAIWO ROAD MARS REMEDIES PVT LTD 635, GIDC ESTATE, WAGHODIA-391 760 DIST.: VADODARA (GUJ.) INDIA GMP- SATIS; LR- SATIS; FEES- PAID; NP: NA 30/08/2018 R R R C4-0471	30/01/2020

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01MA12	Levofloxacin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01M Quinolone antibacterials → J01MA Fluoroquinolones
Discover more medicines within J01MA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	C4-0471